Psychological profile of @entity1 with @entity565 : a comparison with a non- XXXX population and impact on the disease.

@entity1 @entity748 @entity336 @entity1353 @entity565 @entity148
BACKGROUND: Few studies have analysed the relationship between @entity148 and alexithymia with @entity1353 ( @entity1353 ) and its impact on quality of life and @entity565 control. The aim of this study was to assess the prevalence of @entity336 in @entity565 , its impact on quality of life and @entity565 control and its relationship with @entity148 and alexithymia. @entity1 AND METHODS: We performed a cross-sectional study of 264 @entity748 @entity1 and 111 controls. Both groups completed the following questionnaires: quality of life (AQLQ), alexithymia (TAS-20), @entity148 (STAI) and @entity1353 (Nijmegen). In asthmatics were evaluated: @entity565 severity, dyspnoea, exacerbation and control of the disease (ACT test). RESULTS: 38% of asthmatics and 5.5% of non-asthmatics had @entity1353 . Asthmatics had more @entity148 and were more alexithymic. Asthmatics with @entity1353 had significantly more @entity148 , more alexithymia, poor control of @entity565 , more exacerbations and poorer quality of life, that @entity565 without @entity336 . Asthmatics with an ACT<19, a score >3 in the emotion subscale of the AQLQ, who were being treated for @entity148 and scored >19 on the alexithymia subscale that assesses difficulty in identifying emotions, showed ORs for @entity1353 of 2.6 (1.1-5.9), 6.8 (2.9-15.8), 4.4 (1.9-9.8) and 3.3 (1.5-7), respectively. A predictive model of @entity1353 was constructed. CONCLUSIONS: We demonstrated the close relationship between @entity148 , alexithymia and @entity336 in asthmatics, as well as the significant impact of @entity1353 on the control and quality of life of this asthmatics.
